Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Haifeng Eishingdrelo
Institution:
BioInvenu (United States)
Observed institution:
BioInvenu (United States)
ORCID:
0000-0001-7205-1008
Observed ORCID:
0000-0001-7205-1008
OpenAlex ID:
A5101739600
Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery
2013
·
Haifeng Eishingdrelo
·
Current Chemical Genomics
·
80
PDF
ERK and β-Arrestin Interaction: A Converging Point of Signaling Pathways for Multiple Types of Cell Surface Receptors
2014
·
Haifeng Eishingdrelo
, Wei Sun
, et al.
·
SLAS DISCOVERY
·
35
14-3-3 signal adaptor and scaffold proteins mediate GPCR trafficking
2019
·
Luwa Yuan
, Shahar Barbash
, et al.
·
Scientific Reports
·
28
PDF
G-protein-coupled receptors mediate 14-3-3 signal transduction
2016
·
Hua Li
, Alex Eishingdrelo
, et al.
·
Signal Transduction and Targeted Therapy
·
26
PDF
A Cell-Based Protein-Protein Interaction Method Using a Permuted Luciferase Reporter
2011
·
Haifeng Eishingdrelo
, Jidong Cai
, et al.
·
Current Chemical Genomics
·
22
PDF
Modulating GPCR and 14-3-3 protein interactions: Prospects for CNS drug discovery
2023
·
Sathapana Kongsamut
, Haifeng Eishingdrelo
·
Drug Discovery Today
·
9
LPA3 agonist-producing Bacillus velezensis ADS024 is efficacious in multiple neuroinflammatory disease models
2024
·
Susan Acton
, Michelle M. O’Donnell
, et al.
·
Brain Behavior and Immunity
·
5
Ligands can differentially and temporally modulate GPCR interaction with 14-3-3 isoforms
2022
·
Haifeng Eishingdrelo
, Xiaofa Qin
, et al.
·
Current Research in Pharmacology and Drug Discovery
·
5
PDF
Show more works
View as search
Works count:
9
Citation count:
210
H-index:
6
I10-index:
5
Year
Topic
Type
